sur SARTORIUS STED BIO (EPA:DIM)
Sartorius Stedim Biotech Proposes Steady Dividend for 2025
Sartorius Stedim Biotech S.A.'s Board of Directors has resolved to propose a dividend of 0.69 euros per share for the fiscal year 2025, maintaining the same dividend level as 2024. The decision, made on February 4, 2026, will be presented to the Annual Shareholders' Meeting scheduled for March 24, 2026. If approved, this will result in a total distributed profit of 67.1 million euros, with shareholders set to receive their dividends starting April 2, 2026.
The Board also plans to submit the 2025 results at the shareholders' meeting, which have previously been released in a preliminary format. The company's financials and strategic decisions continue to be influenced by various uncertainties and potential risks, as noted in their media release.
Founded in Aubagne, France, Sartorius Stedim Biotech is a significant entity in the biopharmaceutical sector, offering innovative solutions for biotech medication production. The company achieved approximately 3 billion euros in sales revenue for 2025.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de SARTORIUS STED BIO